Short Interest in JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Drops By 25.0%

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOCGet Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 300 shares, a decline of 25.0% from the September 15th total of 400 shares. Based on an average daily volume of 500 shares, the days-to-cover ratio is currently 0.6 days.

Institutional Investors Weigh In On JPMorgan Healthcare Leaders ETF

A hedge fund recently bought a new stake in JPMorgan Healthcare Leaders ETF stock. Ignite Planners LLC purchased a new position in JPMorgan Healthcare Leaders ETF (NASDAQ:JDOCFree Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 3,942 shares of the company’s stock, valued at approximately $230,000. Ignite Planners LLC owned 3.03% of JPMorgan Healthcare Leaders ETF as of its most recent SEC filing.

JPMorgan Healthcare Leaders ETF Stock Up 0.9 %

NASDAQ:JDOC opened at $60.45 on Friday. The business’s 50-day moving average price is $61.37 and its 200 day moving average price is $59.13. The firm has a market cap of $7.86 million, a P/E ratio of 27.37 and a beta of 0.61. JPMorgan Healthcare Leaders ETF has a 52-week low of $48.43 and a 52-week high of $63.49.

JPMorgan Healthcare Leaders ETF Company Profile

(Get Free Report)

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.

Featured Stories

Receive News & Ratings for JPMorgan Healthcare Leaders ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Healthcare Leaders ETF and related companies with MarketBeat.com's FREE daily email newsletter.